Dendritic cells play a role in host susceptibility to Cryptosporidium parvum infection

Immunology Letters

Volumn 158, Issue 1-2, 2014, Pages 42-51

  Bedi, Brahmchetna ^a,b   McNair, Nina N ^b   Mead, Jan R ^a,b  

^a ATLANTA VA MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD11c DTR Tg; Cryptosporidium; Dendritic cells; Innate response

Indexed keywords

GAMMA INTERFERON; GLYCOPROTEIN P 15095; PARASITE ANTIGEN; CD11 ANTIGEN; CYTOKINE; DIPHTHERIA TOXOID;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL STIMULATION; CELLULAR IMMUNITY; COCULTURE; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DENDRITIC CELL; ENGRAFTMENT; HOST SUSCEPTIBILITY; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; INFECTION SENSITIVITY; MOUSE; NONHUMAN; PARASITE LOAD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPOROZOITE; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION; ANIMAL; C57BL MOUSE; DISEASE PREDISPOSITION; GENETICS; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; TH1 CELL; TRANSGENIC MOUSE; TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD11; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; CYTOKINES; DENDRITIC CELLS; DIPHTHERIA TOXOID; DISEASE SUSCEPTIBILITY; HUMANS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; TH1 CELLS;

EID: 84890831592     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2013.11.015     Document Type: Article

References (51)

1. Current W.L., Garcia L.S. Cryptosporidiosis. Clin Microbiol Rev 1991, 4:325-358.
2. Laurent F., McCole D., Eckmann L., Kagnoff M.F. Pathogenesis of Cryptosporidium parvum infection. Microbes Infect 1999, 1:141-148.
3. Davies A.P., Chalmers R.M. Cryptosporidiosis. BMJ 2009, 339:b4168.
4. + T lymphocytes in protective immunity. J Immunol 1991, 147:1014-1022.
5. + cells and gamma interferon in resolution of established Cryptosporidium parvum infection in mice. Infect Immun 1993, 61:3928-3932.
6. + T cells through IL-12 produced by Listeria-induced macrophages. Science 1993, 260:547-549.
7. Manetti R., Parronchi P., Giudizi M.G., Piccinni M.P., Maggi E., Trinchieri G., et al. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 1993, 177:1199-1204.
8. Ehigiator H.N., McNair N., Mead J.R. Cryptosporidium parvum: the contribution of Th1-inducing pathways to the resolution of infection in mice. Exp Parasitol 2007, 115:107-113.
9. Ehigiator H.N., Romagnoli P., Borgelt K., Fernandez M., McNair N., Secor W.E., et al. Mucosal cytokine and antigen-specific responses to Cryptosporidium parvum in IL-12p40 KO mice. Parasite Immunol 2005, 27:17-28.
10. Tessema T.S., Schwamb B., Lochner M., Forster I., Jakobi V., Petry F. Dynamics of gut mucosal and systemic Th1/Th2 cytokine responses in interferon-gamma and interleukin-12p40 knock out mice during primary and challenge Cryptosporidium parvum infection. Immunobiology 2009, 214:454-466.
11. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003, 3:133-146.
12. Ponnuraj E.M., Hayward A.R. Intact intestinal mRNAs and intestinal epithelial cell esterase, but not Cryptosporidium parvum, reach mesenteric lymph nodes of infected mice. J Immunol 2001, 167:5321-5328.
13. Cosyns M., Tsirkin S., Jones M., Flavell R., Kikutani H., Hayward A.R. Requirement of CD40-CD40 ligand interaction for elimination of Cryptosporidium parvum from mice. Infect Immun 1998, 66:603-607.
14. Auray G., Lacroix-Lamande S., Mancassola R., Dimier-Poisson I., Laurent F. Involvement of intestinal epithelial cells in dendritic cell recruitment during C. parvum infection. Microbes Infect 2007, 9:574-582.
15. Bedi B., Mead J.R. Cryptosporidium parvum antigens induce mouse and human dendritic cells to generate Th1-enhancing cytokines. Parasite Immunol 2012, 34:473-485.
16. Saito M., Iwawaki T., Taya C., Yonekawa H., Noda M., Inui Y., et al. Diphtheria toxin receptor-mediated conditional and targeted cell ablation in transgenic mice. Nat Biotechnol 2001, 19:746-750.
17. + T cells by exogenous cell-associated antigens. Immunity 2002, 17:211-220.
18. Arrowood M.J., Mead J.R., Xie L., You X. In vitro anticryptosporidial activity of dinitroaniline herbicides. FEMS Microbiol Lett 1996, 136:245-249.
19. Mead J., McNair N. Antiparasitic activity of flavonoids and isoflavones against Cryptosporidium parvum and Encephalitozoon intestinalis. FEMS Microbiol Lett 2006, 259:153-157.
20. Arrowood M.J., Hurd M.R., Mead J.R. A new method for evaluating experimental cryptosporidial parasite loads using immunofluorescent flow cytometry. J Parasitol 1995, 81:404-409.
21. Benitez A.J., McNair N., Mead J.R. Oral immunization with attenuated Salmonella enterica serovar Typhimurium encoding Cryptosporidium parvum Cp23 and Cp40 antigens induces a specific immune response in mice. Clin Vaccine Immunol 2009, 16:1272-1278.
22. + effector and memory cell populations protect against Cryptosporidium parvum infection. Microbes Infect 2013, 15:599-606.
23. Geem D., Medina-Contreras O., Kim W., Huang C.S., Denning T.L. Isolation and characterization of dendritic cells and macrophages from the mouse intestine. J Vis Exp 2012, e4040.
24. Kaisho T., Takeuchi O., Kawai T., Hoshino K., Akira S. Endotoxin-induced maturation of MyD88-deficient dendritic cells. J Immunol 2001, 166:5688-5694.
25. You X., Mead J.R. Characterization of experimental Cryptosporidium parvum infection in IFN-gamma knockout mice. Parasitology 1998, 117(Pt 6):525-531.
26. Liu C.H., Fan Y.T., Dias A., Esper L., Corn R.A., Bafica A., et al. Cutting edge: dendritic cells are essential for in vivo IL-12 production and development of resistance against Toxoplasma gondii infection in mice. J Immunol 2006, 177:31-35.
27. Probst H.C., Tschannen K., Odermatt B., Schwendener R., Zinkernagel R.M., Van Den Broek M. Histological analysis of CD11c-DTR/GFP mice after in vivo depletion of dendritic cells. Clin Exp Immunol 2005, 141:398-404.
28. Elftman M.D., Gonzalez-Hernandez M.B., Kamada N., Perkins C., Henderson K.S., Nunez G., et al. Multiple effects of dendritic cell depletion on murine norovirus infection. J Gen Virol 2013, 94:1761-1768.
29. Berndt B.E., Zhang M., Chen G.H., Huffnagle G.B., Kao J.Y. The role of dendritic cells in the development of acute dextran sulfate sodium colitis. J Immunol 2007, 179:6255-6262.
30. Denning T.L., Wang Y.C., Patel S.R., Williams I.R., Pulendran B. Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat Immunol 2007, 8:1086-1094.
31. Chang S.Y., Song J.H., Guleng B., Cotoner C.A., Arihiro S., Zhao Y., et al. Circulatory antigen processing by mucosal dendritic cells controls CD8(+) T cell activation. Immunity 2013, 38:153-165.
32. Schreiber H.A., Loschko J., Karssemeijer R.A., Escolano A., Meredith M.M., Mucida D., et al. Intestinal monocytes and macrophages are required for T cell polarization in response to Citrobacter rodentium. J Exp Med 2013, 210:2025-2039.
33. + T cell-induced immune colitis. Am J Physiol Gastrointest Liver Physiol 2011, 300:G939-G947.
34. Westermark L., Fahlgren A., Fallman M. Immune response to diphtheria toxin-mediated depletion complicates the use of the CD11c-DTR(tg) model for studies of bacterial gastrointestinal infections. Microb Pathog 2012, 53:154-161.
35. + cells are required to prevent progression from local acute lung injury to multiple organ failure and death. Am J Pathol 2010, 176:218-226.
36. Steinman R.M., Gutchinov B., Witmer M.D., Nussenzweig M.C. Dendritic cells are the principal stimulators of the primary mixed leukocyte reaction in mice. J Exp Med 1983, 157:613-627.
37. Heath W.R., Carbone F.R. Cross-presentation, dendritic cells, tolerance and immunity. Annu Rev Immunol 2001, 19:47-64.
38. Kim M.G., Kim S.H., Noh H., Ko Y.S., Lee H.Y., Jo S.K., et al. CD11c(+) cells partially mediate the renoprotective effect induced by bone marrow-derived mesenchymal stem cells. PLoS ONE 2013, 8:e72544.
39. + dendritic cells are involved in enhancing herpes simplex virus type 1 latency. J Virol 2008, 82:9870-9879.
40. Plebanski M., Hannan C.M., Behboudi S., Flanagan K.L., Apostolopoulos V., Sinden R.E., et al. Direct processing and presentation of antigen from malaria sporozoites by professional antigen-presenting cells in the induction of CD8 T-cell responses. Immunol Cell Biol 2005, 83:307-312.
41. Cockburn I.A., Tse S.W., Radtke A.J., Srinivasan P., Chen Y.C., Sinnis P., et al. Dendritic cells and hepatocytes use distinct pathways to process protective antigen from plasmodium in vivo. PLoS Pathog 2011, 7:e1001318.
42. Kelsall B.L., Biron C.A., Sharma O., Kaye P.M. Dendritic cells at the host-pathogen interface. Nat Immunol 2002, 3:699-702.
43. Serbina N.V., Salazar-Mather T.P., Biron C.A., Kuziel W.A., Pamer E.G. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 2003, 19:59-70.
44. + dendritic cells during allergen challenge abrogates the characteristic features of asthma. J Exp Med 2005, 201:981-991.
45. Kassim S.H., Rajasagi N.K., Zhao X., Chervenak R., Jennings S.R. In vivo ablation of CD11c-positive dendritic cells increases susceptibility to herpes simplex virus type 1 infection and diminishes NK and T-cell responses. J Virol 2006, 80:3985-3993.
46. Kraal G. Cells in the marginal zone of the spleen. Int Rev Cytol 1992, 132:31-74.
47. Moghimi S.M. Mechanisms of splenic clearance of blood cells and particles: towards development of new splenotropic agents. Adv Drug Deliv Rev 1995, 17:103-115.
48. + T cells: two-faced adaptive immune regulators. Cell Immunol 2010, 264:18-22.
49. Carrion J., Nieto A., Soto M., Alonso C. Adoptive transfer of dendritic cells pulsed with Leishmania infantum nucleosomal histones confers protection against cutaneous leishmaniosis in BALB/c mice. Microbes Infect 2007, 9:735-743.
50. Del Cacho E., Gallego M., Lee S.H., Lillehoj H.S., Quilez J., Lillehoj E.P., et al. Induction of protective immunity against Eimeria tenella infection using antigen-loaded dendritic cells (DC) and DC-derived exosomes. Vaccine 2011, 29:3818-3825.
51. del Cacho E., Gallego M., Lee S.H., Lillehoj H.S., Quilez J., Lillehoj E.P., et al. Induction of protective immunity against Eimeria tenella, Eimeria maxima, and Eimeria acervulina infections using dendritic cell-derived exosomes. Infect Immun 2012, 80:1909-1916.